HRAS and familial pancreatic carcinoma: Nevertheless, we find that Hras is clearly tumor suppressive in pancreatic cancer, at least at early stages of this disease, which could have important ramifications on the susceptibility of developing pancreatic cancer upon oncogenic insult.